Pharmacovigilance
mercredi 25 juin 2025
Sessions parallèles
Sessions parallèles
•
S42
•
16h00
>
17h30
•
Pharmacovigilance
•
IFPS - Amphi 1
Sessions parallèles
Modérateurs : Milou DRICI (Nice), Marie-Blanche VALNET-RABIER (Besançon)
Conférence invitée
16h00 Qualité des études de disproportionnalité - Charles KHOURI (Grenoble)
Communications orales
•
10
•
CO-043 - Characteristics of drug RElated hospitalizations for Nursing HOme residents: Cross-sectional RENHO Study.
>
H.
Haleh
Bagheri
•
186
•
CO-044 - Risk-minimization measures for Nexplanon® migration into the pulmonary artery: what is the 4-year picture?
>
A-P.
Annie-Pierre
Jonville-Bera
•
187
•
CO-045 - Orthostatic hypotension risk associated with antipsychotic use: a systematic review and network meta-analysis, a disproportionality analysis and a pharmacodynamic analysis
>
M.
Maxime
Moiny
•
234
•
CO-046 - Comparison of the safety profile of solriamfetol and pitolisant: a multimodal approach
>
R.
Rémi
Toth
•
238
•
CO-047 - Antipsychotics Rechallenge After Neuroleptic Malignant Syndrome: analysis of the French National Pharmacovigilance Database
>
O.
Olivier
Durlach
•
271
•
CO-048 - Association study between clinical factors and the occurrence of adverse events after antipsychotic treatment in a pediatric population: results from the ETAPE cohort
>
A.
Abd El Kader
Ait Tayeb
|